PBM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Psyence Biomedical Ltd (PBM) is not a good buy for a beginner investor with a long-term strategy at this time. The financial performance is weak, with significant losses in net income and EPS. Additionally, there are no strong trading signals, positive catalysts, or recent news to support a buy decision. The technical indicators suggest a bearish trend, and the stock lacks momentum for a long-term investment.
The MACD is positive but contracting, indicating weakening momentum. RSI is neutral at 68.392, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Key support is at 2.328, and resistance is at 2.603. The stock shows a 60% chance of minor gains in the short term but lacks a strong upward trend.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
Weak financial performance with significant YoY declines in net income (-632.44%) and EPS (-142.23%). Bearish moving averages and lack of trading momentum.
In 2026/Q2, revenue remained at 0 with no growth. Net income dropped significantly to -753,254 (-632.44% YoY), and EPS fell to -3.18 (-142.23% YoY). Gross margin remained at 0 with no improvement.
No analyst ratings or price target changes available.
